Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma
Multiple rodent and primate preclinical studies have advanced CAR T cells into the clinic. However, no single model accurately reflects the challenges of effective CAR T therapy in human cancer patients. To evaluate the effectiveness of next-generation CAR T cells that aim to overcome barriers to du...
Main Authors: | M. Kazim Panjwani, Matthew J. Atherton, Martha A. MaloneyHuss, Kumudhini P. Haran, Ailian Xiong, Minnal Gupta, Irina Kulikovsaya, Simon F. Lacey, Nicola J. Mason |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2019.1676615 |
Similar Items
-
Case Report: Clinical and Serological Hallmarks of Cytokine Release Syndrome in a Canine B Cell Lymphoma Patient Treated With Autologous CAR-T Cells
by: Matthew J. Atherton, et al.
Published: (2022-07-01) -
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma
by: Valerie Wittibschlager, et al.
Published: (2023-03-01) -
Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells
by: Jia Feng, et al.
Published: (2022-09-01) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
by: Sergey Kulemzin, et al.
Published: (2021-11-01) -
CAR-Based Approaches to Cutaneous T-Cell Lymphoma
by: Irene Scarfò, et al.
Published: (2019-04-01)